Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion type Assertion NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_head.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion evidence source_evidence_literature NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion SIO_000772 19698268 NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion wasDerivedFrom befree-20140225 NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.
- NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion wasGeneratedBy ECO_0000203 NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.